In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus

Wang Q, Xiao ZX, Zheng X, Wang G, Yang L, Shi L, Xiang N, Wang X, Zha GF, Schett G, Chen Z (2025)

Publication Type: Journal article

Publication year: 2025

Journal

New England Journal of Medicine Massachusetts Medical Society

Book Volume: 393

Pages Range: 1542-1544

Journal Issue: 15

DOI: 10.1056/NEJMc2509522

Authors with CRIS profile

Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

Shenzhen MagicRNA Biotech / 虹信生物 CN China (CN) Anqing Municipal Hospital / 安庆市立医院 CN China (CN) Anhui University of Science and Technology (AUST) / 安徽理工大学 CN China (CN)

How to cite

APA:

Wang, Q., Xiao, Z.X., Zheng, X., Wang, G., Yang, L., Shi, L.,... Chen, Z. (2025). In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus. New England Journal of Medicine, 393(15), 1542-1544. https://doi.org/10.1056/NEJMc2509522

MLA:

Wang, Qian, et al. "In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus." New England Journal of Medicine 393.15 (2025): 1542-1544.

BibTeX: Download